Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
89.4M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
11.8M
-
Shares change
-
-12.7M
-
Total reported value, excl. options
-
$9.46M
-
Value change
-
-$26M
-
Put/Call ratio
-
0.21
-
Number of buys
-
20
-
Number of sells
-
-26
-
Price
-
$0.80
Significant Holders of Milestone Pharmaceuticals Inc. - Common Shares (MIST) as of Q1 2025
64 filings reported holding MIST - Milestone Pharmaceuticals Inc. - Common Shares as of Q1 2025.
Milestone Pharmaceuticals Inc. - Common Shares (MIST) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.8M shares
of 89.4M outstanding shares and own 13.23% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (2.51M shares), Propel Bio Management, LLC (1.45M shares), Alta Fundamental Advisers LLC (1.43M shares), BML Capital Management, LLC (1.14M shares), MORGAN STANLEY (969K shares), Simplify Asset Management Inc. (850K shares), TORONTO DOMINION BANK (750K shares), Lion Point Capital, LP (549K shares), Bleichroeder LP (500K shares), and MILLENNIUM MANAGEMENT LLC (322K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.